Visceral Steatosis

Visceral Steatosis(来自ICD-11)
别称:
Fatty Metamorphosis of Viscera
Steatohepatitis
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Visceral Steatosis, also known as fatty metamorphosis of viscera, is related to visceral steatosis, congenital and metabolic dysfunction-associated steatotic liver disease. An important gene associated with Visceral Steatosis is SLC22A5 (Solute Carrier Family 22 Member 5). The drugs Alogliptin and Ursodeoxycholic acid have been mentioned in the context of this disorder. Affiliated tissues include liver and heart.
查看原文 参与反馈

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
--
Unknown
--
1
7
--

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top